|4May 23, 1:36 PM ET

MERIDIAN BIOSCIENCE INC 4

4 · MERIDIAN BIOSCIENCE INC · Filed May 23, 2017

Insider Transaction Report

Form 4
Period: 2017-05-19
Elagin Vecheslav A
Sr VP, Research & Development
Transactions
  • Award

    Stock Options (Right to Buy)

    2017-05-19+10,00010,000 total
    Exercise: $13.60Exp: 2027-05-19Common Stock (10,000 underlying)
Holdings
  • Common Stock

    (indirect: By 401(k))
    79
  • Common Stock

    52,926
Footnotes (1)
  • [F1]These options are awarded under the 2012 Stock Incentive Plan in connection with promotion to Executive Vice President, Research & Development and Chief Scientific Officer, and vest in four equal installments from the date of grant (i.e., 25% per year until fully vested on May 19, 2021).

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT